Efficacy of up-front 5-fluorouracil - Epidoxorubicin - cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients
E. Van Der Wall, E. J.T. Rutgers, M. J. Holtkamp, J. W. Baars, J. H. Schornagel, J. L. Peterse, J. H. Beijnen, S. Rodenhuis
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Efficacy of up-front 5-fluorouracil - Epidoxorubicin - cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients'. Together they form a unique fingerprint.